Cardiol Therapeutics (CRDL) Stock Price, Quote, News & History

Q: What sector and industry does Cardiol Therapeutics (CRDL) operate in?

Cardiol Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Cardiol Therapeutics (CRDL) Stock Price, Quote, News & History

CRDLNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$0.9600

-0.05-4.95%

At close: Feb 4, 4:00 PM EST

$0.9600

-0.05-4.95%

Pre-Market: 4:39 AM EST

Overview

News Earnings Options Analyst Ratings Short Interest Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

-

Close

$0.96

Volume / Avg.

95.00 / 456.67K

Day Range

- - -

52 Wk Range

0.77 - 1.59

Market Cap

$106.96M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

38

Short Interest

1.96%

Days to Cover

7.1

Recent Cardiol Therapeutics Inc News

Why MongoDB Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

This Visa Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Avi Kapoor

3 Penny Stocks Ready to Break Out in 2025

Known for their uncommonly pronounced risk/reward profile, penny stocks all too often entice investors with their low prices and potential for significant returns, only to fail to live up to those expectations. The

MarketBeat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-24.22M

Investing Cash Flow (TTM)

-27.56K

Financing Cash Flow (TTM)

18.68M

Free Cash Flow (TTM)

-24.25M

Capital Expenditure (TTM)

-27.56K

Net Change in Cash (TTM)

-5.57M

Analyst Trends and Forecast

1

Dec 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$98.61M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

15.33

Earnings Yield % (TTM)

-31.24%

Earnings Yield % (FWD)

-33.53%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.06

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$55.38K

Total Cash

$11.62M

Debt to Equity

0.01

Issuance of Debt (TTM)

-$55.38K

Repayment of Debt (TTM)

-$55.38K

Key Statistics

Open

-

Close

$0.96

Volume / Avg.

95.00 / 456.67K

Day Range

- - -

52 Wk Range

0.77 - 1.59

Market Cap

$106.96M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

38

Short Interest

1.96%

Days to Cover

7.1

About

Sector

Health Care

Industry

Pharmaceuticals

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx,...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Cardiol Therapeutics (CRDL) stock?

A

You can purchase shares of Cardiol Therapeutics (NASDAQ:CRDL) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Cardiol Therapeutics (CRDL) competitors?

A

Other companies in Cardiol Therapeutics’s space includes: MediWound Ltd (NASDAQ:MDWD), Cumberland Pharmaceuticals Inc (NASDAQ:CPIX), Rani Therapeutics Holdings Inc (NASDAQ:RANI), Incannex Healthcare Inc (NASDAQ:IXHL) and High Tide Inc (NASDAQ:HITI).

Q

What is the forecast, or price target, for Cardiol Therapeutics (CRDL) stock?

A

Cardiol Therapeutics has a consensus price target of $7.80.

Q

What is the current price for Cardiol Therapeutics (CRDL)?

A

The stock price for Cardiol Therapeutics (NASDAQ: CRDL) is $0.96 last updated February 5, 2026 at 5:53 PM EST.

Q

Does Cardiol Therapeutics (CRDL) pay a dividend?

A

There are no upcoming dividends for Cardiol Therapeutics.

Q

When is Cardiol Therapeutics (NASDAQ:CRDL) reporting earnings?

A

Cardiol Therapeutics does not have any upcoming earnings scheduled.

Q

Is Cardiol Therapeutics (CRDL) going to split?

A

There is no upcoming split for Cardiol Therapeutics.

Q

What sector and industry does Cardiol Therapeutics (CRDL) operate in?

A

Cardiol Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch

Cumberland Pharmaceuticals Inc

NASDAQ:CPIX

$3.43

-4.66%

Rani Therapeutics Holdings Inc

NASDAQ:RANI

$1.13

2.65%

Incannex Healthcare Inc

Sol-Gel Technologies Ltd

NASDAQ:SLGL

$66.40

2.56%

Milestone Pharmaceuticals Inc

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

-

Close

$0.96

Volume / Avg.

95.00 / 456.67K

Day Range

- - -

52 Wk Range

0.77 - 1.59

Market Cap

$106.96M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

38

Short Interest

1.96%

Days to Cover

7.1

Recent Cardiol Therapeutics Inc News

Why MongoDB Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

This Visa Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Avi Kapoor

3 Penny Stocks Ready to Break Out in 2025

Known for their uncommonly pronounced risk/reward profile, penny stocks all too often entice investors with their low prices and potential for significant returns, only to fail to live up to those expectations. The

MarketBeat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-24.22M

Investing Cash Flow (TTM)

-27.56K

Financing Cash Flow (TTM)

18.68M

Free Cash Flow (TTM)

-24.25M

Capital Expenditure (TTM)

-27.56K

Net Change in Cash (TTM)

-5.57M

Analyst Trends and Forecast

1

Dec 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$98.61M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

15.33

Earnings Yield % (TTM)

-31.24%

Earnings Yield % (FWD)

-33.53%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.06

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$55.38K

Total Cash

$11.62M

Debt to Equity

0.01

Issuance of Debt (TTM)

-$55.38K

Repayment of Debt (TTM)

-$55.38K

Key Statistics

Open

-

Close

$0.96

Volume / Avg.

95.00 / 456.67K

Day Range

- - -

52 Wk Range

0.77 - 1.59

Market Cap

$106.96M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

38

Short Interest

1.96%

Days to Cover

7.1

About

Sector

Health Care

Industry

Pharmaceuticals

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx,...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry